SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

11 Jul 2023 Evaluate
The total revenue for the June 2023 quarter zoomed 114.01% to Rs. 65.08 millions as compared to Rs. 30.41 millions during the year-ago period.The Company's Net profit for the June 2023 quarter have declined marginally to Rs. 0.80  millions as against Rs. 0.84 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 3.03 millions from 3.57 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 65.08 30.41 114.01 65.08 30.41 114.01 183.21 254.32 -27.96
Other Income 0.27 2.35 -88.51 0.27 2.35 -88.51 8.55 6.53 30.93
PBIDT 3.03 3.57 -15.13 3.03 3.57 -15.13 18.10 19.68 -8.03
Interest 0.34 0.88 -61.36 0.34 0.88 -61.36 1.50 4.64 -67.67
PBDT 2.69 2.69 0.00 2.69 2.69 0.00 16.60 15.04 10.37
Depreciation 1.60 1.57 1.91 1.60 1.57 1.91 6.33 5.62 12.63
PBT 1.09 1.12 -2.68 1.09 1.12 -2.68 10.27 9.42 9.02
TAX 0.29 0.28 3.57 0.29 0.28 3.57 2.57 2.36 8.90
Deferred Tax 0.29 0.28 3.57 0.29 0.28 3.57 2.09 2.34 -10.68
PAT 0.80 0.84 -4.76 0.80 0.84 -4.76 7.70 7.06 9.07
Equity 83.16 83.16 0.00 83.16 83.16 0.00 83.16 83.16 0.00
PBIDTM(%) 4.66 11.74 -60.34 4.66 11.74 -60.34 9.88 7.74 27.67

Eiko Lifesciences Share Price

49.60 -0.86 (-1.70%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×